Megan Baierlein Email

Chief Operating Officer . Trace Neuroscience

Current Roles

Employees:
21
Revenue:
$3.3M
About
Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
Trace Neuroscience Address

San Francisco, CA
United States
Trace Neuroscience Email

Past Companies

T-knifeSenior Vice President and Chief Operating Officer
Audentes TherapeuticsSenior Vice President and Chief Operating Officer
Audentes TherapeuticsSenior Vice President, Program Management and Operations